• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of dry gene powder for lung and evaluation of its efficacy

Research Project

Project/Area Number 15590050
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Physical pharmacy
Research InstitutionMeijo University

Principal Investigator

OKAMOTO Hirokazu  Meijo University, Faculty of Pharmacy, Associate Professor, 薬学部, 助教授 (00308941)

Co-Investigator(Kenkyū-buntansha) IIDA Kotaro  Meijo University, Faculty of Pharmacy, Lecturer, 薬学部, 講師 (40121488)
Project Period (FY) 2003 – 2004
Project Status Completed (Fiscal Year 2004)
Budget Amount *help
¥2,800,000 (Direct Cost: ¥2,800,000)
Fiscal Year 2004: ¥900,000 (Direct Cost: ¥900,000)
Fiscal Year 2003: ¥1,900,000 (Direct Cost: ¥1,900,000)
Keywordsgene therapy / lung cancer / drug delivery system / inhalation / interferon / chitosan / supercritical carbon dioxide / dry powder
Research Abstract

Recent y precipitation of powders with supercritical carbon dioxide- (SCF) has been attracting much attention as a method to produce tarry partides with high functionality We have already reported that the gene powders grew cl by the SCF prep bad improved stability and iir aced gene expression in lungs after intratracheal insufflation in mice. In the present study, we prepared chitosan-interferon β (DNA) powders by the SCF process to exannne the therapeutics of there in murinelung metastasis model
An bus :solution of pCMV-MuBβ a plasmid DNA cabling murine intern β, and chitosan, a nonviral vector was dispersed in SCF with ethanol as a modifier to precipitate them. Mannitol was used as a powder vehicle. To establish a lung metasitatis, CT26, mouse colon carcinoma cells, were injected intravenously into mouse tail vein. The DNA powder or solution was administered intratracheally or intravenously to examine the lung weighty, number of metastatic nodules, and survival rate with time. The ge … More ne expression after intratracheal administration of DNA was abserved in normal and cancer tissue in the lung, while no expression was observed in the other organs. The DNA powders suppressed the increase in lung weight and number of nodules and prolonged the survival of the mice with smaller dose of DNA than DNA solutions. Intratracheal administration was more effective than intravenous administration. These findings suggested that the DNA powders prepared by the SCF processs had high therapeutic potential in murine lung metastasis model.
The next study examined the stability of a gene in powers prepared with supercritical carbon dioxide (CO2) from the viewpoints of the ternary structure of DNA and in vivo inch potential. An aqueous chitosan-pCMV-Luc complex solution containing mannitol was injected into the stream of a supercritical CO2/ethanol admixture to precipitate a gene powder. The obtained gem powders and gene solutions were placed in stability chambers at 25 or 40゜C for 4 weeks. The integrity, and transfection potency of the gene were examined by electrophoresis and in van pulmonary transfection study in mice The supercritical CO2 process decreased the sided DNA doting the manufacturing process; however, the decrease in the remaining supercoiled and open circular DNA in the powders during storage was much slower than that in solutions. In addition, the powders had W war w on potency than the solutions containing the same amount of DNA. The effect of chitosan on the stability of DNA in solutions was not obvious in the solutions but it improved the stability of DNA in powders du manufacturing and storage. Thus, a gene powder with a vector is a promising formulation for a ready-to use inhalation therapy of pulmonary diseases. Less

Report

(3 results)
  • 2004 Annual Research Report   Final Research Report Summary
  • 2003 Annual Research Report
  • Research Products

    (7 results)

All 2005 2004

All Journal Article (6 results) Book (1 results)

  • [Journal Article] Stability of Chitosan-Pdna Complex Powder Prepared by Supercritical Carbon Dioxide Process2005

    • Author(s)
      Hirokazu Okamoto
    • Journal Title

      International Journal of Pharmaceutics 290(1-2)

      Pages: 73-81

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Annual Research Report 2004 Final Research Report Summary
  • [Journal Article] 肺がん治療を目的とした遺伝子ドライパウダーの開発と有効性の評価2005

    • Author(s)
      岡本浩一
    • Journal Title

      名城大学総合研究所紀要 10(印刷中)

    • NAID

      40007079612

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Annual Research Report 2004 Final Research Report Summary
  • [Journal Article] ポストゲノム時代の微粒子吸入療法2005

    • Author(s)
      岡本浩一
    • Journal Title

      粉体工学会誌 42(5)

      Pages: 333-341

    • NAID

      10015696083

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Development and Evaluation of Gene Powder for Inhalation Therapy of Lung Cancer2005

    • Author(s)
      Hirokazu Okamoto
    • Journal Title

      Bulletin of Research Institute of Meijo University 10(in press)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Inhalation Therapy in the Post-Gnome Era2005

    • Author(s)
      Hirokazu Okamoto
    • Journal Title

      J.Soc.Powder Thchnol.Jap. 42(5)

      Pages: 333-341

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Functional Microparticles of Medicies2004

    • Author(s)
      Hirokazu Okamoto
    • Journal Title

      Nanotechnology with Supercritical Fluids (ed. by Tadafumi Adschiri) (CMC Press, Tokyo)

      Pages: 159-164

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Book] 超臨界流体とナノテクノロジー(阿尻雅文編)第3章6.7機能性医薬品微粒子2004

    • Author(s)
      岡本浩一
    • Publisher
      シーエムシー出版
    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary

URL: 

Published: 2003-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi